{"id":"W4293354639","doi":"10.1056/nejmoa2206286","title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2658,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université de Montréal; Montreal Heart Institute","funders":"AstraZeneca","keywords":"Ejection fraction; Dapagliflozin; Heart failure; Cardiology; Internal medicine; Medicine; Diabetes mellitus; Endocrinology; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}